Investors’ Patience Is Being Tested Right Now By Apellis Pharmaceuticals Inc (NASDAQ: APLS)

After Hours

The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.

Stocks Info

Apellis Pharmaceuticals Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Apellis Pharmaceuticals Inc is $2.52B. A total of 3.85 million shares were traded on the day, compared to an average of 2.06M shares.

In the most recent transaction, Chopas James George sold 183 shares of APLS for 24.82 per share on Mar 17 ’25. After the transaction, the VP/Chief Accounting Officer now owns 47,955 company shares. In a previous transaction on Mar 17 ’25, Chopas James George bought 183 shares at 24.82 per share.

Among the insiders who sold shares, Watson David O. disposed of 5,569 shares on Mar 05 ’25 at a per-share price of $25.10. This resulted in the General Counsel holding 138,730 shares of APLS after the transaction. In another insider transaction, DAVID OSBORNE WATSON bought 5,569 shares at $25.10 per share on Mar 05 ’25.

Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, APLS has a high of $49.06 and a low of $16.98.

As of this writing, APLS has an earnings estimate of -$0.34 per share for the current quarter. EPS was calculated based on a consensus of 9.0 estimates, with a high estimate of -$0.2 per share and a lower estimate of -$0.47.

Balance Sheet Annually/Quarterly

A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. APLS’s latest balance sheet shows that the firm has $700.55M in Cash & Short Term Investments as of fiscal 2021. There were $210.22M in debt and $131.85M in liabilities at the time. Its Book Value Per Share was $1.84, while its Total Shareholder’s Equity was $198.66M.

Analysts Opinion

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for APLS is Buy with a score of 4.26.

Most Popular

Related Posts